129 related articles for article (PubMed ID: 6723893)
21. Fasciola hepatica: tegumental changes induced in vitro by the deacetylated (amine) metabolite of diamphenethide.
Fairweather I; Anderson HR; Threadgold LT
Exp Parasitol; 1986 Dec; 62(3):336-48. PubMed ID: 3780927
[TBL] [Abstract][Full Text] [Related]
22. Comparative efficacy of triclabendazole, nitroxynil and rafoxanide against immature and mature Fasciola hepatica in naturally infected cattle.
Rapic D; Dzakula N; Sakar D; Richards RJ
Vet Rec; 1988 Jan; 122(3):59-62. PubMed ID: 3354156
[TBL] [Abstract][Full Text] [Related]
23. Fasciola hepatica: tegumental surface alterations following treatment in vitro with the deacetylated (amine) metabolite of diamphenethide.
Fairweather I; Anderson HR; Baldwin TM
Parasitol Res; 1987; 73(2):99-106. PubMed ID: 3575297
[TBL] [Abstract][Full Text] [Related]
24. The interaction between the deacetylated (amine) metabolite of diamphenethide (DAMD) and cytochemically demonstrable Na+/K+-ATPase activity in the tegument of Fasciola hepatica.
Skuce PJ; Anderson HR; Fairweather I
Parasitol Res; 1987; 74(2):161-7. PubMed ID: 2830613
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of an injectable combination anthelmintic (nitroxynil+clorsulon+ivermectin) against early immature Fasciola hepatica compared to triclabendazole combination flukicides given orally or topically to cattle.
Hutchinson GW; Dawson K; Fitzgibbon CC; Martin PJ
Vet Parasitol; 2009 Jun; 162(3-4):278-84. PubMed ID: 19375232
[TBL] [Abstract][Full Text] [Related]
26. The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.
Robinson MW; Lawson J; Trudgett A; Hoey EM; Fairweather I
Parasitol Res; 2004 Feb; 92(3):205-10. PubMed ID: 14652740
[TBL] [Abstract][Full Text] [Related]
27. Fasciola hepatica: the effects of neuropharmacological agents upon in vitro motility.
Holmes SD; Fairweather I
Exp Parasitol; 1984 Oct; 58(2):194-208. PubMed ID: 6148259
[TBL] [Abstract][Full Text] [Related]
28. Comparative activity of anthelmintic drugs, mebendazole, praziquantel and albendazole against Hymenolepis diminuta in experimentally infected rats.
Galal M; Chin SR
Rev Elev Med Vet Pays Trop; 1987; 40(2):147-50. PubMed ID: 3453505
[No Abstract] [Full Text] [Related]
29. Field trial on comparative efficacy of four fasciolicides against natural liver fluke infection in cattle.
Elitok B; Elitok OM; Kabu M
Vet Parasitol; 2006 Feb; 135(3-4):279-85. PubMed ID: 16289862
[TBL] [Abstract][Full Text] [Related]
30. Fasciola hepatica: morphological changes in vitelline cells following treatment in vitro with the deacetylated (amine) metabolite of diamphenethide (DAMD).
Fairweather I; Anderson HR; Threadgold LT
Int J Parasitol; 1988 Dec; 18(8):1061-9. PubMed ID: 3220646
[No Abstract] [Full Text] [Related]
31. [Glycogen synthetase in helminths. Inhibition by benzimidazoles].
Gómez-Banqueri H; García Ruiz MA; Monteoliva M; Sánchez-Moreno M
Rev Inst Med Trop Sao Paulo; 1987; 29(4):200-4. PubMed ID: 3130654
[No Abstract] [Full Text] [Related]
32. Experiments on anthelmintic control of Fasciola hepatica in Brazil.
Echevarria FA; Correa MB; Wehrle RD; Correa IF
Vet Parasitol; 1992 Jul; 43(3-4):211-22. PubMed ID: 1413453
[TBL] [Abstract][Full Text] [Related]
33. The effect of the sulphoxide metabolite of triclabendazole ('Fasinex') on the tegument of mature and immature stages of the liver fluke, Fasciola hepatica.
Stitt AW; Fairweather I
Parasitology; 1994 Jun; 108 ( Pt 5)():555-67. PubMed ID: 8052511
[TBL] [Abstract][Full Text] [Related]
34. Fasciola hepatica: scanning electron microscopic observations of juvenile flukes following treatment in vitro with the deacetylated (amine) metabolite of diamphenethide (DAMD).
Anderson HR; Fairweather I
Int J Parasitol; 1988 Sep; 18(6):827-37. PubMed ID: 3192355
[No Abstract] [Full Text] [Related]
35. Fasciola hepatica: ultrastructural changes to the tegument of juvenile flukes following incubation in vitro with the deacetylated (amine) metabolite of diamphenethide.
Anderson HR; Fairweather I
Int J Parasitol; 1995 Mar; 25(3):319-33. PubMed ID: 7601590
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the activity of some fasciolicides against immature liver fluke in calves.
Dobbins SE; Wellington AC
Vet Rec; 1982 Aug; 111(9):177-8. PubMed ID: 6753310
[TBL] [Abstract][Full Text] [Related]
37. Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica.
Halferty L; Brennan GP; Trudgett A; Hoey L; Fairweather I
Vet Parasitol; 2009 Feb; 159(2):126-38. PubMed ID: 19027238
[TBL] [Abstract][Full Text] [Related]
38. Isothermal microcalorimetry to study the activity of triclabendazole and its metabolites on juvenile and adult Fasciola hepatica.
Keiser J; Manneck T; Kirchhofer C; Braissant O
Exp Parasitol; 2013 Mar; 133(3):265-8. PubMed ID: 23206957
[TBL] [Abstract][Full Text] [Related]
39. Resistance of Fasciola hepatica to triclabendazole and albendazole in sheep in Spain.
Alvarez-Sánchez MA; Mainar-Jaime RC; Pérez-García J; Rojo-Vázquez FA
Vet Rec; 2006 Sep; 159(13):424-5. PubMed ID: 16998003
[No Abstract] [Full Text] [Related]
40. Assessment of flukicide efficacy against Fasciola hepatica in sheep in Sweden in the absence of a standardised test.
Novobilský A; Amaya Solis N; Skarin M; Höglund J
Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):141-147. PubMed ID: 27380550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
